Back to results
US 2026/0272873 A1Published application
Composition for preventing or treating cancer, containing manassantin a and immune checkpoint inhibitor or epithelial growth factor receptor inhibitor
AssigneeKyungpook National University Industry-Academic Cooperation Foundation
InventorYou-Mie LEE
Life of this patent
Estimating the term…
Abstract
Provided is a method for preventing and/or treating cancer, the method including administering to a subject a composition containing manassantin and an immune checkpoint inhibitor, or manassantin A and an epithelial growth factor receptor inhibitor, as active ingredients. The composition of the presently claimed subject matter is expected to be effectively used to suppress, through co-administration, the proliferation, metastasis, relapse, or resistance to anticancer therapy of various solid cancers.
Claims5
A method for treating cancer, the method comprising:
- administering a pharmaceutically effective amount of a composition comprising manassantin A and an epidermal growth factor receptor (EGFR) inhibitor as active ingredients to the subject in need thereof.
Dependencies are inferred from the claim text.